Patient characteristics and treatment outcomes in the validation part 1.
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://figshare.com/articles/dataset/Patient_characteristics_and_treatment_outcomes_in_the_validation_part_1_/26439073
下载链接
链接失效反馈官方服务：
资源简介：
The parameters are as follows: Sex (M; Male, F; Female), Number of Pembrolizumab doses (N of Pembrolizumab doses), Progression-Free Survival in days (PFS (days)), Age, Pathology (type of cancer, in this case, Adenocarcinoma), and Red Cell Distribution Width (RDW).
(XLSX)
创建时间：
2024-08-01
